Comorbidities

Comorbidities

Recorded: Thursday, October 17, 2024 - Friday, October 18, 2024
On-Demand Session

Overview

Patients receiving addiction treatment frequently present with medical and psychological conditions that can greatly affect their overall well-being. This 1-hour, 45-minute, on-demand session from the 2024 ASAM State of the Art Course discusses research and treatment approaches for common co-occurring disorders, such as HIV, hepatitis, infectious diseases, and stress and trauma.

This session is comprised of 4 presentations that deep dive into different aspects of the overall topic.

• Early Liver Transplantation for Severe Alcoholic Hepatitis
  The most common cause of liver failure requiring liver transplantation in the United States is excessive alcohol consumption. Without liver transplantation, patients with Alcohol Associated Hepatitis (AAH) that fail medical management have survival rates of ~30%. U.S. Transplant teams encountered substantial increases in the prevalence of AAH in younger, sicker patients with short sobriety subsequent to the COVID-19 Pandemic. This session will describe two new outpatient programs developed to improve treatment adherence and reduce relapse in this high-risk population; 1. "Total Recovery", a 12-week program exclusively for liver transplant patients with Alcohol Use Disorders; 2. "The Integrated Liver Transplant Engagement and Recovery Network (ILEARN)", an NIH-funded, co-located program for Post-Liver Transplant Management of Alcohol Use Disorders.
• Implementing a Peer-Supported, Integrated Strategy for Substance Use Disorder Care in an Outpatient Infectious Disease Clinic is Associated with Improved Patient Outcomes
  The RESTORE service (REcovery in Specialty care Through medication and OutREach) was established in January 2019 at Johns Hopkins Hospital in Baltimore City, Maryland, to improve access to SUD treatment and recovery services among patients with multiple comorbidities, including HIV and HCV. This session will describe the experiences and preliminary outcomes of a co-located substance use disorder (SUD) treatment and recovery service within an outpatient infectious disease specialty clinic. The presentation will cover the program funding, design, implementation and research findings. Despite the disruptions that COVID-19 pandemic caused, the high retention rates and low overdose risk observed in the multicomponent program demonstrated the effectiveness of the program.
• HIV & Addiction: Long-Acting Injectable Therapy for People with HIV
  This session will review long acting cabotegravir/rilpivirine (LA-CAB/RPV) including the drug classes, dosing, and administration. It will review the current evidence around its use in people who inject drugs (PWID) with comorbid HIV. The session will also describe in detail a current clinic's implementation of LA-CAB/RPV in PWID including in those not virally suppressed.
• The PROUD Study: Promoting Resilience for Medicaid Members with Opioid Use Disorder During Climate and Environmental Stressors
  This session will review findings of the PROUD (Promoting Resilience Among Medicaid Members with Opioid Use Disorder) study. This community partnered, participatory study assessed experiences of care for Medicaid members with opioid use disorder faced with environmental stressors such as hurricanes, floods, and pandemic surges. The presenter will review policy opportunities which may mitigate interruptions in care during major environmental stressors.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Deadline: 10/1/2027

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Credits & Disclosures

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available

• Physicians: 1.75 Credit(s)
• Nurses & NPs: 1.75 Nursing Contact Hour(s)
• Pharmacology Hour(s): 0.5 Hour(s)
• PAs: 1.75 Credit(s)
• Pharmacists: 1.75 Credit(s)
• Interprofessional Continuing Education: 1.75 Credit(s)
• Certified Counselors: NBCC Contact Hours Not offered

 American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.

Maintenance of Certification (MOC)/Continuing Certification Program (CCP)

This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

• ABA MOCA 2.0®*: 1.75 Lifelong Learning
• ABIM MOC Points: 1.75 Medical Knowledge
• ABP MOC: 1.75 Lifelong Learning & Self-Assessment
• ABS Continuing Certification: 1.75 Accredited CME | 1.75 Self-Assessment

Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.

• American Board of Addiction Medicine (ABAM)
• American Board of Preventative Medicine (ABPM)
• American Board of Psychiatry and Neurology (ABPN)
• Royal College of Physicians and Surgeons of Canada (RCPSC)

Certificates for other professions

All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the patient safety CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

See the attached pdf for a list of disclosures.